Loading
Latest filing published 30 Nov 2022 for CytoDyn Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Antonio Migliarese in CytoDyn Inc., where the filings describe the role as finance chief. In total, 18 filings cover trades dated from 6 August 2021 to 30 November 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 30 November 2022 came the latest disclosure, a share grant in CytoDyn Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations